Target intelligence / Profile preview

VAV3 antisense RNA 1 (VAV3-AS1)

Target
VAV3-AS1
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA, Other
01

Overview

VAV3 antisense RNA 1 (VAV3-AS1) is a long non-coding RNA gene, also referred to as LINC02785. This gene produces RNA transcripts that do not encode proteins and is classified within the group of long intergenic non-protein coding RNAs (lncRNAs)[1]. The specific biological functions, interactions, disease associations, or roles as biomarkers or drug targets are currently not well annotated in the literature or by major biological databases, and there is no evidence that VAV3-AS1 is a direct target for therapeutics. VAV3-AS1 is distinct from the protein-coding gene VAV3, which plays a role in guanine nucleotide exchange and cell signaling[3][4]; VAV3-AS1 is its antisense non-coding counterpart[1]. All references to VAV3 gene function, interactions, and disease are not applicable to VAV3-AS1 unless future research directly demonstrates overlap. VAV3 antisense RNA 1 (VAV3-AS1, LINC02785) is a long non-coding RNA gene with no established therapeutic target status, disease role, or drug interactions, and is classified under long non-coding RNAs. Its detailed functional characterization remains undetermined in available gene databases[1].

Other names
LINC02785VAV3 antisense RNA 1 (non-protein coding)Long intergenic non-protein coding RNA 2785VAV3-AS1
02

Mechanism of action

Not applicable; as a long non-coding RNA, it is not known to be a direct target for drugs, so no mechanism of action is associated

03

Biological functions

RNA-based regulation of gene expressionOther
04

Disease associations

Other
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on VAV3 antisense RNA 1 (VAV3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VAV3 antisense RNA 1 (VAV3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call